These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 32262501)

  • 1. Cationic liposomes as efficient nanocarriers for the drug delivery of an anticancer cholesterol-based ruthenium complex.
    Vitiello G; Luchini A; D'Errico G; Santamaria R; Capuozzo A; Irace C; Montesarchio D; Paduano L
    J Mater Chem B; 2015 Apr; 3(15):3011-3023. PubMed ID: 32262501
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anticancer cationic ruthenium nanovectors: from rational molecular design to cellular uptake and bioactivity.
    Mangiapia G; Vitiello G; Irace C; Santamaria R; Colonna A; Angelico R; Radulescu A; D'Errico G; Montesarchio D; Paduano L
    Biomacromolecules; 2013 Aug; 14(8):2549-60. PubMed ID: 23705931
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cholesterol-based nucleolipid-ruthenium complex stabilized by lipid aggregates for antineoplastic therapy.
    Simeone L; Mangiapia G; Vitiello G; Irace C; Colonna A; Ortona O; Montesarchio D; Paduano L
    Bioconjug Chem; 2012 Apr; 23(4):758-70. PubMed ID: 22369596
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ruthenium-based complex nanocarriers for cancer therapy.
    Mangiapia G; D'Errico G; Simeone L; Irace C; Radulescu A; Di Pascale A; Colonna A; Montesarchio D; Paduano L
    Biomaterials; 2012 May; 33(14):3770-82. PubMed ID: 22357152
    [TBL] [Abstract][Full Text] [Related]  

  • 5. "Dressing up" an Old Drug: An Aminoacyl Lipid for the Functionalization of Ru(III)-Based Anticancer Agents.
    Riccardi C; Musumeci D; Capuozzo A; Irace C; King S; Russo Krauss I; Paduano L; Montesarchio D
    ACS Biomater Sci Eng; 2018 Jan; 4(1):163-174. PubMed ID: 33418686
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Investigating the Interaction of an Anticancer Nucleolipidic Ru(III) Complex with Human Serum Proteins: A Spectroscopic Study.
    Riccardi C; Campanella A; Montesarchio D; Del Vecchio P; Oliva R; Paduano L
    Molecules; 2023 Mar; 28(6):. PubMed ID: 36985771
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A new design for nucleolipid-based Ru(III) complexes as anticancer agents.
    Montesarchio D; Mangiapia G; Vitiello G; Musumeci D; Irace C; Santamaria R; D'Errico G; Paduano L
    Dalton Trans; 2013 Dec; 42(48):16697-708. PubMed ID: 24121739
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Triple Negative Breast Cancer Preclinical Therapeutic Management by a Cationic Ruthenium-Based Nucleolipid Nanosystem.
    Ferraro MG; Bocchetti M; Riccardi C; Trifuoggi M; Paduano L; Montesarchio D; Misso G; Santamaria R; Piccolo M; Irace C
    Int J Mol Sci; 2023 Mar; 24(7):. PubMed ID: 37047448
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Safety and Efficacy Evaluation In Vivo of a Cationic Nucleolipid Nanosystem for the Nanodelivery of a Ruthenium(III) Complex with Superior Anticancer Bioactivity.
    Piccolo M; Ferraro MG; Raucci F; Riccardi C; Saviano A; Russo Krauss I; Trifuoggi M; Caraglia M; Paduano L; Montesarchio D; Maione F; Misso G; Santamaria R; Irace C
    Cancers (Basel); 2021 Oct; 13(20):. PubMed ID: 34680314
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and evaluation of mono- and multi-hydroxyl low toxicity pH-sensitive cationic lipids for drug delivery.
    Zhao Z; Yao W; Wang N; Liu C; Zhou H; Chen H; Qiao W
    Eur J Pharm Sci; 2019 May; 133():69-78. PubMed ID: 30914360
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of cationic lipids on the stability and membrane properties of paclitaxel-containing liposomes.
    Campbell RB; Balasubramanian SV; Straubinger RM
    J Pharm Sci; 2001 Aug; 90(8):1091-105. PubMed ID: 11536214
    [TBL] [Abstract][Full Text] [Related]  

  • 12. siRNA delivery to lung-metastasized tumor by systemic injection with cationic liposomes.
    Hattori Y; Nakamura A; Arai S; Kawano K; Maitani Y; Yonemochi E
    J Liposome Res; 2015; 25(4):279-86. PubMed ID: 25543847
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Polyethylene glycol-complexed cationic liposome for enhanced cellular uptake and anticancer activity.
    Jung SH; Jung SH; Seong H; Cho SH; Jeong KS; Shin BC
    Int J Pharm; 2009 Dec; 382(1-2):254-61. PubMed ID: 19666094
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Polymeric micelle-mediated delivery of half-sandwich ruthenium(II) complexes with phosphanes derived from fluoroloquinolones for lung adenocarcinoma treatment.
    Kołoczek P; Skórska-Stania A; Cierniak A; Sebastian V; Komarnicka UK; Płotek M; Kyzioł A
    Eur J Pharm Biopharm; 2018 Jul; 128():69-81. PubMed ID: 29678734
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhancement of the uptake and cytotoxic activity of doxorubicin in cancer cells by novel cRGD-semipeptide-anchoring liposomes.
    Battistini L; Burreddu P; Sartori A; Arosio D; Manzoni L; Paduano L; D'Errico G; Sala R; Reia L; Bonomini S; Rassu G; Zanardi F
    Mol Pharm; 2014 Jul; 11(7):2280-93. PubMed ID: 24819754
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Folate-PEG coated cationic modified chitosan--cholesterol liposomes for tumor-targeted drug delivery.
    Wang H; Zhao P; Liang X; Gong X; Song T; Niu R; Chang J
    Biomaterials; 2010 May; 31(14):4129-38. PubMed ID: 20163853
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Electrostatic parameters of cationic liposomes commonly used for gene delivery as determined by 4-heptadecyl-7-hydroxycoumarin.
    Zuidam NJ; Barenholz Y
    Biochim Biophys Acta; 1997 Oct; 1329(2):211-22. PubMed ID: 9371413
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of "helper lipid" on lipoplex electrostatics.
    Hirsch-Lerner D; Zhang M; Eliyahu H; Ferrari ME; Wheeler CJ; Barenholz Y
    Biochim Biophys Acta; 2005 Aug; 1714(2):71-84. PubMed ID: 16051183
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Conjugation of a Ru(II) arene complex to neomycin or to guanidinoneomycin leads to compounds with differential cytotoxicities and accumulation between cancer and normal cells.
    Grau-Campistany A; Massaguer A; Carrion-Salip D; Barragán F; Artigas G; López-Senín P; Moreno V; Marchán V
    Mol Pharm; 2013 May; 10(5):1964-76. PubMed ID: 23510087
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ruthenium complex delivery using liposomes to improve bioactivity against HeLa cells via the mitochondrial pathway.
    Guo B; Liao C; Fang Y; Li S; Li X; Lu Z; Chen Y
    Nanomedicine (Lond); 2018 Nov; 13(22):2851-2866. PubMed ID: 30457036
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.